Dodge & Cox Adds $122M in UnitedHealth Group Incorporated ($UNH)
Dodge & Cox added nearly 294,000 shares of UnitedHealth Group, raising its stake by 3.2%.
Key Points
- Dodge & Cox increased its UnitedHealth Group stake by 3.2%, adding 293,987 shares for a total of 9,466,756 shares.
- UnitedHealth Group, trading near $408.19, has a market cap of $368.3 billion and a P/E ratio of 30.6.
- The company offers healthcare services through segments like Optum Health and UnitedHealthcare, with a dividend yield of 2.29%.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Dodge & Cox has boosted its position in UnitedHealth Group Incorporated, adding 293,987 shares. This increase, reported in its latest Form 13F filing, reflects a 3.2% growth in its holdings, bringing its total to 9,466,756 shares valued at approximately $3.86 billion. The filing covers the reporting period and may not represent the investor's current position.
What Changed in Dodge & Cox's UnitedHealth Group Position
Dodge & Cox's recent activity saw its stake in UnitedHealth Group grow significantly. The fund added 293,987 shares, increasing its position by 3.2% to a total of 9,466,756 shares. This move represents a substantial investment in the healthcare giant, with a reported value of about $3.86 billion.
UnitedHealth Group Incorporated Stock Up 6.7%
Shares of UnitedHealth Group traded around $408.19. The company boasts a substantial market capitalization of $368.3 billion and a P/E ratio of 30.6, indicating its profitability relative to its share price. With a beta of 0.65, the stock shows less volatility compared to the market. Over the past year, its share price has fluctuated between $234.60 and $415.98. The stock's 50-day moving average is $407.46, while the 200-day moving average wasn't provided.
$UNH stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
UnitedHealth Group is expected to announce its next earnings on July 16, 2026. The company has been performing steadily, with an EPS of 13.26. It operates with a solid revenue stream and maintains a competitive position in the healthcare industry.
Dividend
UnitedHealth Group offers a dividend yield of 2.29%, providing income to its shareholders. The company's consistent dividend payments reflect its stable financial health and commitment to returning value to investors.
About UnitedHealth Group
UnitedHealth Group Incorporated is a leading healthcare company based in Eden Prairie, Minnesota. It operates through various segments, including Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare. The company offers a wide range of services such as care delivery, pharmacy services, and health benefit plans. Under the leadership of CEO Stephen J. Hemsley, UnitedHealth Group employs around 390,000 people, serving both U.S. and international markets.
Bottom Line
Dodge & Cox's increased stake in UnitedHealth Group highlights its confidence in the healthcare leader's long-term prospects. Investors often track such filings to gauge institutional sentiment, though it's important to remember these reports are backward-looking and may not reflect current positions.
Get UnitedHealth Group Incorporated alerts
New 13F filings, insider trades, and analyst moves on $UNH, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.
